These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2553475)

  • 1. Tumour markers in the clinical management of patients with small cell lung cancer.
    Hansen M; Hansen HH
    Eur Respir J; 1989 Sep; 2(8):700-1. PubMed ID: 2553475
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined measurements of neuron specific enolase and bombesin/gastrin releasing peptide in lung cancer.
    Scagliotti GV; Piani M; Gatti E; Gozzelino F; Albera C; Pozzi E
    Eur Respir J; 1989 Sep; 2(8):746-50. PubMed ID: 2553476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
    Schneider J; Philipp M; Salewski L; Velcovsky HG
    Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
    Stieber P; Dienemann H; Schalhorn A; Schmitt UM; Reinmiedl J; Hofmann K; Yamaguchi K
    Anticancer Res; 1999; 19(4A):2673-8. PubMed ID: 10470218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma gastrin-releasing peptide analysis and the clinical significance].
    Maruno K; Yamaguchi K; Abe K
    Nihon Rinsho; 1990 Feb; 48 Suppl():100-3. PubMed ID: 2162407
    [No Abstract]   [Full Text] [Related]  

  • 6. Value of tumour and inflammatory markers in lung cancer.
    Oremek GM; Sauer-Eppel H; Bruzdziak TH
    Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of serum neuron-specific enolase as a tumor marker in lung cancer].
    Yonei T; Ohnoshi T; Hiraki S; Yamashita H; Ishii J; Egawa T; Kozuka A; Moritaka T; Uji H; Yoshida M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Feb; 26(2):139-44. PubMed ID: 2841525
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical significance of tumor markers CYFRA 21-1 and neuron-specific enolase in lung cancer].
    Kushlinskiĭ NE; Liubimova NV; Lemeshko AO; Vasil'ev AV; Davydov MI
    Biull Eksp Biol Med; 1997 Jan; 123(1):98-100. PubMed ID: 9213472
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum neuron-specific enolase (NSE) in patients with primary lung cancer].
    Oribe H; Kato R; Noguchi S; Kai T
    Rinsho Byori; 1988 Apr; 36(4):464-8. PubMed ID: 2841516
    [No Abstract]   [Full Text] [Related]  

  • 10. Pro-gastrin-releasing peptide (Pro-GRP), a tumor marker for small cell lung cancer.
    Oremek GM; Sapoutzis N
    Anticancer Res; 2003; 23(2A):895-8. PubMed ID: 12820319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological markers in lung cancer].
    Nikliński J; Furman M
    Pneumonol Alergol Pol; 1991; 59(5-6):253-9. PubMed ID: 1668877
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of serum NSE (neuron specific enolase) levels in cases of small cell lung cancer].
    Moriya H; Hisa S; Satoh T; Suzuki S; Kimura K; Higuchi Y; Hoshi K
    Rinsho Hoshasen; 1988 Jan; 33(1):31-4. PubMed ID: 2835529
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neuron specific enolase (NSE)].
    Odagiri E
    Nihon Rinsho; 1999 Dec; 57 Suppl():540-2. PubMed ID: 10778185
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical value of neuron specific enolase and tissue polipeptidic antigen for the management of patients with lung cancer.
    Spinazzi A; Soresi E; Borghini U; Boffi R; Vigorelli R; Scoccia S
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):141-5. PubMed ID: 1965446
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gastrin-releasing peptide as a specific tumor marker in patients with small cell lung carcinoma, compared with neuron-specific enolase].
    Maruno K
    Nihon Geka Gakkai Zasshi; 1990 Jun; 91(6):760-5. PubMed ID: 2169019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor markers in lung cancer].
    Niho S; Shinkai T
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):2089-93. PubMed ID: 11791391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of ProGRP31-98 in patients with small-cell lung cancer].
    Yang J; Li R; Li A
    Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):216-8. PubMed ID: 11778234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of serum NSE assay as a tumor marker].
    Ariyoshi Y; Kuwabara M
    Nihon Rinsho; 1990 Feb; 48 Suppl():1035-7. PubMed ID: 2162410
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pro gastrin-releasing peptide (ProGRP)].
    Ishikawa H; Saito T
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():759-61. PubMed ID: 16149633
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of neurone-specific enolase and pro-gastrin releasing peptide in the prognostic evaluation of small cell lung cancer patients.
    Satoh H; Kagohashi K; Kurishima K; Ishikawa H; Ohtsuka M
    Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):720. PubMed ID: 17100161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.